Globus Medical (GMED)

NYSE Health Care Health Care Equipment S&P MidCap 400

$71.05

-10.39 (-12.76%)

Close of Nov 06, 2026 · end-of-day data

Source: Globus Medical's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$563.99M	$635.98M	$712.97M	$785.37M	$789.04M	$958.10M	$1.02B	$1.57B	$2.52B	$2.94B
Cost of revenue	$134.71M	$150.45M	$159.41M	$179.97M	$217.46M	$239.22M	$263.73M	$548.17M	$1.04B	$957.80M
Gross profit	$429.29M	$485.52M	$553.56M	$605.39M	$571.58M	$718.88M	$759.12M	$1.02B	$1.48B	$1.98B
Research & development	$44.53M	$43.68M	$55.50M	$60.07M	$84.52M	$97.35M	$73.02M	$124.01M	$163.75M	$147.25M
Selling, general & admin	$222.16M	$267.82M	$311.59M	$354.76M	$354.76M	$408.15M	$432.12M	$643.84M	$981.36M	$1.18B
Operating income	$154.14M	$161.84M	$169.32M	$171.99M	$111.43M	$171.95M	$227.95M	$133.14M	$165.99M	$479.82M
Pre-tax income	$157.28M	$169.93M	$188.60M	$189.95M	$125.90M	$180.41M	$243.02M	$165.39M	$120.72M	$605.07M
Income tax	$52.94M	$62.58M	$32.13M	$34.74M	$23.61M	$31.22M	$52.85M	$42.52M	$17.74M	$67.20M
Net income	$104.34M	$107.35M	$156.47M	$155.21M	$102.28M	$149.19M	$190.17M	$122.87M	$102.98M	$537.87M
EBITDA	$192.91M	$203.91M	$210.96M	$224.72M	$174.31M	$241.82M	$296.20M	$278.67M	$419.38M	$756.66M
EPS (basic)	$1.09	$1.12	$1.60	$1.57	$1.04	$1.48	$1.89	$1.09	$0.76	$3.98
EPS (diluted)	$1.08	$1.10	$1.54	$1.52	$1.01	$1.44	$1.85	$1.07	$0.75	$3.92
Diluted shares	96.43M	97.89M	101.32M	102.00M	100.97M	103.62M	102.64M	114.63M	137.86M	137.06M
Gross margin	76.1%	76.3%	77.6%	77.1%	72.4%	75.0%	74.2%	65.1%	58.9%	67.4%
Operating margin	27.3%	25.4%	23.7%	21.9%	14.1%	17.9%	22.3%	8.5%	6.6%	16.3%
Net margin	18.5%	16.9%	21.9%	19.8%	13.0%	15.6%	18.6%	7.8%	4.1%	18.3%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$66.95M	$118.82M	$139.65M	$195.47M	$239.40M	$193.07M	$150.47M	$467.29M	$784.44M	$526.16M
Short-term investments	—	$254.89M	$199.94M	$115.76M	$187.34M	$250.38M	$295.59M	$50.50M	$105.62M	$31.09M
Receivables	$91.98M	$116.68M	$137.07M	$154.33M	$141.68M	$164.44M	$213.25M	$503.24M	$557.70M	$678.94M
Inventory	$112.69M	$108.41M	$131.25M	$196.31M	$229.15M	$237.00M	$298.98M	$848.13M	$659.23M	$759.28M
Total current assets	$513.77M	$620.34M	$630.68M	$687.47M	$821.76M	$864.52M	$983.34M	$1.92B	$2.18B	$2.13B
Goodwill	$105.93M	$123.89M	$123.73M	$128.78M	$156.72M	$179.71M	$197.47M	$1.43B	$1.43B	$1.44B
Total assets	$927.64M	$1.08B	$1.30B	$1.53B	$1.68B	$1.96B	$2.08B	$5.09B	$5.25B	$5.30B
Total current liabilities	$79.89M	$93.07M	$96.12M	$111.40M	$120.79M	$140.16M	$159.20M	$392.35M	$855.91M	$498.50M
Total liabilities	$95.56M	$110.72M	$115.15M	$129.62M	$173.19M	$215.88M	$229.75M	$1.09B	$1.07B	$729.51M
Shareholders' equity	$832.08M	$967.78M	$1.19B	$1.40B	$1.51B	$1.74B	$1.85B	$4.00B	$4.18B	$4.57B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$147.82M	$159.06M	$181.64M	$171.97M	$198.79M	$276.27M	$178.47M	$243.50M	$520.64M	$753.45M
Capital expenditures	$40.91M	$51.30M	$59.70M	$70.75M	$63.66M	$56.90M	$74.05M	$78.27M	$115.43M	$164.68M
Free cash flow	$106.91M	$107.75M	$121.95M	$101.22M	$135.13M	$219.38M	$104.42M	$165.22M	$405.21M	$588.77M
Investing cash flow	-$162.74M	-$111.28M	-$193.03M	-$140.28M	-$117.32M	-$375.94M	-$110.36M	$302.97M	-$176.05M	-$355.01M
Financing cash flow	$470.00K	$1.63M	$32.57M	$24.44M	-$38.66M	$54.15M	-$109.96M	-$231.82M	-$27.70M	-$679.16M
Share buybacks	—	—	—	—	$104.67M	—	$144.49M	$225.56M	$85.79M	$300.45M
Stock-based compensation	$11.38M	$14.69M	$21.90M	$26.09M	$27.07M	$30.59M	$32.81M	$52.74M	$54.19M	$49.78M
Depreciation & amortization	$38.77M	$42.07M	$41.63M	$52.73M	$62.87M	$69.87M	$68.25M	$145.53M	$253.39M	$276.84M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$616.53M	$606.67M	$629.69M	$625.71M	$657.29M	$598.12M	$745.34M	$769.05M	$826.42M	$759.85M	$789.61M	$763.72M
Cost of revenue	$265.49M	$241.49M	$260.04M	$270.51M	$263.44M	$195.40M	$248.76M	$252.53M	$261.11M	$234.07M	$241.44M	$232.92M
Gross profit	$351.05M	$365.18M	$369.65M	$355.19M	$393.86M	$402.72M	$496.58M	$516.51M	$565.31M	$525.79M	$548.17M	$530.80M
Research & development	$52.25M	$57.27M	$37.70M	$35.38M	$33.41M	$33.06M	$39.95M	$38.07M	$36.16M	$36.51M	$36.32M	$34.53M
Selling, general & admin	$245.15M	$248.68M	$239.45M	$240.06M	$253.17M	$242.80M	$303.62M	$313.60M	$318.48M	$297.77M	$286.82M	$288.47M
Operating income	$10.12M	$8.00M	$49.62M	$48.10M	$60.27M	$97.00M	$76.11M	$137.36M	$169.34M	$150.39M	$182.43M	$177.55M
Pre-tax income	$24.99M	-$8.56M	$47.58M	$57.03M	$24.67M	$103.67M	$188.17M	$143.99M	$169.23M	$157.07M	$189.82M	$183.27M
Income tax	$9.96M	-$1.44M	$15.82M	$5.20M	-$1.84M	$28.21M	-$14.67M	$25.03M	$28.64M	$32.77M	$38.25M	$42.10M
Net income	$15.03M	-$7.12M	$31.76M	$51.84M	$26.50M	$75.46M	$202.85M	$118.97M	$140.59M	$124.30M	$151.57M	$141.17M
EBITDA	$82.08M	$63.26M	$113.21M	$115.05M	$127.87M	$162.66M	$146.74M	$208.44M	$238.82M	$220.24M	$251.93M	$247.93M
EPS (basic)	$0.06	$-0.05	$0.23	$0.38	$0.20	$0.55	$1.50	$0.88	$1.05	$0.92	$1.12	$1.05
EPS (diluted)	$0.09	$-0.05	$0.23	$0.38	$0.19	$0.54	$1.49	$0.88	$1.02	$0.90	$1.10	$1.04
Diluted shares	4.57M	135.36M	136.98M	138.06M	618.00K	139.77M	136.50M	135.39M	-163.00K	138.19M	137.38M	136.02M
Gross margin	56.9%	60.2%	58.7%	56.8%	59.9%	67.3%	66.6%	67.2%	68.4%	69.2%	69.4%	69.5%
Operating margin	1.6%	1.3%	7.9%	7.7%	9.2%	16.2%	10.2%	17.9%	20.5%	19.8%	23.1%	23.2%
Net margin	2.4%	-1.2%	5.0%	8.3%	4.0%	12.6%	27.2%	15.5%	17.0%	16.4%	19.2%	18.5%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$467.29M	$354.06M	$410.42M	$622.77M	$784.44M	$461.27M	$229.45M	$371.77M	$526.16M	$560.95M	$507.75M	$441.27M
Short-term investments	$50.50M	$80.41M	$82.51M	$71.94M	$105.62M	—	—	$18.75M	$31.09M	$68.90M	$87.40M	$76.16M
Receivables	$503.24M	$534.33M	$611.78M	$588.05M	$557.70M	$535.09M	$611.57M	$619.12M	$678.94M	$686.43M	$692.18M	$675.30M
Inventory	$848.13M	$816.20M	$770.46M	$717.70M	$659.23M	$663.60M	$772.13M	$771.54M	$759.28M	$772.60M	$810.90M	$824.14M
Total current assets	$1.92B	$1.83B	$1.92B	$2.06B	$2.18B	$1.71B	$1.73B	$1.92B	$2.13B	$2.20B	$2.22B	$2.18B
Goodwill	$1.43B	$1.45B	$1.45B	$1.43B	$1.43B	$1.43B	$1.43B	$1.43B	$1.44B	$1.44B	$1.44B	$1.45B
Total assets	$5.09B	$4.94B	$4.99B	$5.09B	$5.25B	$4.71B	$4.96B	$5.10B	$5.30B	$5.44B	$5.49B	$5.53B
Total current liabilities	$392.35M	$786.32M	$794.15M	$818.07M	$855.91M	$384.70M	$424.66M	$465.96M	$498.50M	$482.46M	$479.35M	$507.94M
Total liabilities	$1.09B	$1.02B	$1.02B	$1.02B	$1.07B	$623.08M	$665.41M	$696.82M	$729.51M	$707.24M	$719.65M	$731.94M
Shareholders' equity	$4.00B	$3.92B	$3.98B	$4.07B	$4.18B	$4.09B	$4.30B	$4.40B	$4.57B	$4.73B	$4.77B	$4.80B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$104.67M	$52.39M	$54.26M	$203.65M	$210.34M	$177.30M	$77.86M	$249.69M	$248.59M	$202.36M	$209.74M	$265.23M
Capital expenditures	$22.88M	$28.57M	$27.80M	$41.95M	$17.11M	$36.10M	$46.56M	$35.82M	$46.20M	$39.62M	$33.17M	$40.39M
Free cash flow	$81.79M	$23.82M	$26.46M	$161.70M	$193.23M	$141.20M	$31.30M	$213.88M	$202.39M	$162.75M	$176.57M	$224.84M
Investing cash flow	$320.62M	-$46.58M	-$10.38M	-$14.97M	-$104.12M	$131.38M	-$299.11M	-$75.84M	-$111.45M	-$182.67M	-$129.05M	-$155.90M
Financing cash flow	-$237.27M	-$115.72M	$8.71M	$19.58M	$59.73M	-$635.40M	-$24.94M	-$32.04M	$13.21M	$18.20M	-$134.50M	-$130.76M
Share buybacks	—	$83.32M	$1.47M	$0	$1.00M	$190.45M	$25.00M	$40.00M	$45.00M	$0	$136.06M	$142.94M
Stock-based compensation	$12.45M	$17.26M	$12.81M	$12.21M	$11.91M	$13.21M	$13.62M	$11.54M	$11.42M	$12.62M	$13.38M	$11.74M
Depreciation & amortization	$71.95M	$55.26M	$63.59M	$66.95M	$67.59M	$65.65M	$70.63M	$71.07M	$69.48M	$69.86M	$69.50M	$70.38M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.